Category stocks

Teladoc Health Q2 Earnings Call Highlights

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend Teladoc Health (NYSE:TDOC) reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected profitability in its Integrated Care segment, while lower cash-pay revenue at... <

X Money Does Not Add Up

If ever a new product range was an example of a solution to a problem that does not exist, X Money is it. Elon Musk threatened, I should probably say promised, a banking tool linked to X, way back in 2022, when he paid a ridiculous amount of money to acquire Twitter <p